For example, activated AKT kinase is beneficial for cancer cell proliferation and survival, while SETDB1 could activate AKT by mediating methylation of AKT K64 residue and promote the development of non-small-cell lung carcinoma (NSCLC) (Wang et al., 2019). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.